Literature DB >> 12454009

Endotoxin enhances liver alcohol dehydrogenase by action through upstream stimulatory factor but not by nuclear factor-kappa B.

James J Potter1, Lynda Rennie-Tankersley, Esteban Mezey.   

Abstract

Liver alcohol dehydrogenase (ADH) is increased by physiological stress and by chronic administration of growth hormone (GH). Endotoxin plays a role in the pathogenesis of alcoholic liver disease. The effect of lipopolysaccharide (LPS), the endotoxin component of Gram-negative bacteria, was determined on liver ADH. LPS given daily to rats for 3 days increased ADH mRNA, ADH protein, and ADH activity. Nuclear factor-kappaB (NF-kappaB) in the liver nuclear extracts bound to an oligonucleotide specifying region -226 to -194 of the ADH promoter, whereas upstream stimulatory factor (USF) was shown previously to bind to a more proximal site. LPS increased NF-kappaB and USF binding to the ADH promoter. The NF-kappaB (p65) and NF-kappaB (p50) expression vectors inhibited the transfected ADH promoter activity, which contrasts with the previously demonstrated stimulation by an USF expression vector. The binding activities of STAT5b and of C/EBPbeta, which mediate the effect of GH on ADH, were not changed or decreased, respectively, by LPS, indicating that GH plays no intermediary role in the effect of LPS. This study shows that LPS increases ADH and that this effect is mediated by increased binding of USF to the ADH promoter and not by NF-kappaB, which has an inhibitory action.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454009     DOI: 10.1074/jbc.M210097200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  In vitro profiling of endothelial volatile organic compounds under resting and pro-inflammatory conditions.

Authors:  V Longo; A Forleo; S Capone; E Scoditti; M A Carluccio; P Siciliano; M Massaro
Journal:  Metabolomics       Date:  2019-10-03       Impact factor: 4.290

2.  Coordinated dynamic gene expression changes in the central nucleus of the amygdala during alcohol withdrawal.

Authors:  Kate Freeman; Mary M Staehle; Rajanikanth Vadigepalli; Gregory E Gonye; Babatunde A Ogunnaike; Jan B Hoek; James S Schwaber
Journal:  Alcohol Clin Exp Res       Date:  2012-07-24       Impact factor: 3.455

3.  Alcohol dehydrogenase: a potential new marker for diagnosis of intestinal ischemia using rat as a model.

Authors:  Upendra R Gumaste; Mukund M Joshi; Devendra T Mourya; Pradip V Barde; Ghanshyam K Shrivastav; Vikram S Ghole
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

4.  Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver.

Authors:  Devanshi Seth; Maria A Leo; Peter H McGuinness; Charles S Lieber; Yvonne Brennan; Rohan Williams; Xin M Wang; Geoffrey W McCaughan; Mark D Gorrell; Paul S Haber
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

5.  Venous diethylene glycol poisoning in patients with preexisting severe liver disease in China.

Authors:  Bing-Liang Lin; Zhi-Xin Zhao; Yu-Tian Chong; Jian-Guo Li; Xing Zuo; Yu Tao; Tan-Qi Lou; Zhi-Liang Gao
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

6.  The inflammatory and normal transcriptome of mouse bladder detrusor and mucosa.

Authors:  Marcia R Saban; Helen L Hellmich; Mary Turner; Ngoc-Bich Nguyen; Rajanikanth Vadigepalli; David W Dyer; Robert E Hurst; Michael Centola; Ricardo Saban
Journal:  BMC Physiol       Date:  2006-01-18

Review 7.  Alcohol Metabolizing Enzymes, Microsomal Ethanol Oxidizing System, Cytochrome P450 2E1, Catalase, and Aldehyde Dehydrogenase in Alcohol-Associated Liver Disease.

Authors:  Yanchao Jiang; Ting Zhang; Praveen Kusumanchi; Sen Han; Zhihong Yang; Suthat Liangpunsakul
Journal:  Biomedicines       Date:  2020-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.